2023-07-01 2024-06-30 false Capium Accounts Production 1.1 12068936 2023-07-01 2024-06-30 12068936 bus:FullAccounts 2023-07-01 2024-06-30 12068936 bus:FRS102 2023-07-01 2024-06-30 12068936 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 12068936 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 12068936 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 12068936 2023-07-01 2024-06-30 12068936 2024-06-30 12068936 bus:RegisteredOffice 2023-07-01 2024-06-30 12068936 core:WithinOneYear 2024-06-30 12068936 core:AfterOneYear 2024-06-30 12068936 1 2023-07-01 2024-06-30 12068936 bus:Director1 2023-07-01 2024-06-30 12068936 bus:Director1 2024-06-30 12068936 bus:Director1 2022-07-01 2023-06-30 12068936 bus:Director2 2023-07-01 2024-06-30 12068936 bus:Director2 2024-06-30 12068936 bus:Director2 2022-07-01 2023-06-30 12068936 2022-07-01 12068936 bus:LeadAgentIfApplicable 2023-07-01 2024-06-30 12068936 2022-07-01 2023-06-30 12068936 2023-06-30 12068936 core:WithinOneYear 2023-06-30 12068936 core:AfterOneYear 2023-06-30 12068936 bus:EntityAccountantsOrAuditors 2022-07-01 2023-06-30 12068936 core:PlantMachinery 2023-07-01 2024-06-30 12068936 core:PlantMachinery 2024-06-30 12068936 core:PlantMachinery 2023-06-30 12068936 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-06-30 12068936 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-06-30 12068936 core:CostValuation core:Non-currentFinancialInstruments 2024-06-30 12068936 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 12068936 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-06-30 12068936 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 12068936 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 12068936 core:Non-currentFinancialInstruments 2024-06-30 12068936 core:Non-currentFinancialInstruments 2023-06-30 12068936 core:ShareCapital 2024-06-30 12068936 core:ShareCapital 2023-06-30 12068936 core:RetainedEarningsAccumulatedLosses 2024-06-30 12068936 core:RetainedEarningsAccumulatedLosses 2023-06-30 12068936 dpl:Item1 2023-07-01 12068936 dpl:Item1 2024-06-30 12068936 dpl:Item1 2022-07-01 12068936 dpl:Item1 2023-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12068936
England and Wales

 

 

 

KARE HEALTHCARE LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 July 2023

End date: 30 June 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 1,499    1,763 
1,499    1,763 
Current assets      
Debtors 4 21,000    36,643 
Cash at bank and in hand 19,848    50,382 
40,848    87,025 
Creditors: amount falling due within one year 5 (10,492)   (78,447)
Net current assets 30,356    8,578 
 
Total assets less current liabilities 31,855    10,341 
Creditors: amount falling due after more than one year 6 (18,991)   (23,328)
Net assets 12,864    (12,987)
 

Capital and reserves
     
Called up share capital 2    2 
Profit and loss account 12,862    (12,989)
Shareholders' funds 12,864    (12,987)
 


For the year ended 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 28 March 2025 and were signed on its behalf by:


-------------------------------
DR RUMANA NAYEEM
Director
-------------------------------
FRANCES NKOLI NRI
Director
1
General Information
KARE HEALTHCARE LTD is a private company, limited by shares, registered in England and Wales, registration number 12068936, registration address 246 - 250 Romford Road, City Gate House, London, E7 9HZ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 15% Reducing Balance
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Total
  £   £
At 01 July 2023  
Additions 2,150    2,150 
Disposals  
At 30 June 2024 2,150    2,150 
Depreciation
At 01 July 2023 387    387 
Charge for year 264    264 
On disposals  
At 30 June 2024 651    651 
Net book values
Closing balance as at 30 June 2024 1,499    1,499 
Opening balance as at 01 July 2023 1,763    1,763 


4.

Debtors: amounts falling due within one year

2024
£
  2023
£
Amount Owed by Participating Interests 21,000    36,643 
21,000    36,643 

5.

Creditors: amount falling due within one year

2024
£
  2023
£
Amounts Owed to Participating Interests   73,559 
Corporation Tax 3,085   
Accrued Expenses 4,992    2,472 
Other Creditors 1    2 
Directors' Current Accounts 2,414    2,414 
10,492    78,447 

6.

Creditors: amount falling due after more than one year

2024
£
  2023
£
Bank Loans & Overdrafts 18,991    23,328 
18,991    23,328 

2